Depend on GENEWIZ to support your pre-clinical and clinical regulatory submissions. Our state-of-the-art US laboratory is compliant with FDA and EPA Good Laboratory Practices (GLP) and accredited by the College of American Pathologists (CAP)/Clinical Laboratory Improvement Amendments (CLIA).
By joining together with Brooks Life Sciences, we now offer a complete solution to support all your clinical and regulatory needs. From sample collection and storage, through to sample processing, sequencing, analysis, and reporting. Operating with the highest-quality standards, our flexible services are customized to meet each customer’s unique specifications.
Sequence confirmation support throughout pre-clinical development and clinical trials
Orthogonal testing for validation of in vitro diagnostic accuracy to support US FDA CDRH medical device applications
Confirmation of deleterious patient genomic alterations utilizing orthogonal platform technologies in support of diagnostics
Confirmation of known biomarkers in pre-clinical and clinical samples
Confirmation of viral, bacterial, and human cell lines and cell banks, pre- and post- manufacturing, prior to use in therapeutics
GLP GMO and plant strain Identification, as per 40CFR part 160 for EPA compliance
Brooks Life Sciences offers sample kitting and cold-chain logistics with real-time sample tracking to securely transport samples to our storage facilities.
Samples are stored in Brooks Life Sciences’ CAP ISO 9001-accredited, GXP-compliant facilities with 24/7 access to our 21 CFR Part 11- compliant software.
GENEWIZ’s pre-analytical processing, such as extractions, PMBC isolations, and aliquoting, are performed in our CAP-accredited, GXP-compliant laboratories.
Custom assay development and validations to support specific regulatory submissions
Ph.D.-level support during your entire project, including free consultations
Superior data quality that exceeds manufacturer’s benchmarks